@misc{TeuschlFuchsFeichtingeretal.,
  author    = {Teuschl, Andreas and Fuchs, Christiane and Feichtinger, Georg and Heher, Philipp and Heimel, Patrick and Schuh, Christina and N{\"u}rnberger, Sylvia and Nau, Thomas and R{\"u}nzler, Dominik and Redl, Heinz},
  title     = {Fibrin or Fibroin - Not only the "o" Makes the Difference},
  subject      = {Fibrin},
  language  = {en}
}
@article{WeihsFuchsTeuschletal.,
  author    = {Weihs, Anna and Fuchs, Christiane and Teuschl, Andreas and Hartinger, Joachim and Slezak, Paul and Mittermayr, Rainer and Redl, Heinz and Junger, Wolfgang and Sitte, Harald and R{\"u}nzler, Dominik},
  title     = {Shock Wave Treatment Enhances Cell Proliferation and Improves Wound Healing by ATP Release-coupled Extracellular Signal-regulated Kinase (ERK) Activation},
  series = {The Journal of biological chemistry},
  journal   = {The Journal of biological chemistry},
  subject      = {Shockwave},
  language  = {de}
}
@misc{Fuchs,
  author    = {Fuchs, Christiane},
  title     = {Shockwave treatment promotes proliferation via purinergic signaling coupled ERK1/2 pathway activation},
  subject      = {Shockwave},
  language  = {en}
}
@misc{HeherFuchsPruelleretal.,
  author    = {Heher, Philipp and Fuchs, Christiane and Pr{\"u}ller, Johanna and Maleiner, Babette and Kollmitzer, Josef and R{\"u}nzler, Dominik and Teuschl, Andreas and Wolbank, Susanne and Redl, Heinz},
  title     = {A bioreactor-based 3D culture system for skeletal muscle engineering in fibrin scaffolds},
  subject      = {Bioreactors},
  language  = {en}
}
@article{ButaDavidDresseletal.,
  author    = {Buta, Christiane and David, Robert and Dressel, Ralf and Emgard, Mia and Fuchs, Christiane and Gross, Ulrike and Healy, Lyn and Hescheler, J{\"u}rgen and Kolar, Roman and Martin, Ulrich and Mikkers, Harald and M{\"u}ller, Franz-Josef and Schneider, Rebekka and Seiler, Andrea and Spielmann, Horst and Weitzer, Georg},
  title     = {REconsidering pluripotency tests: do we still need teratoma assays?},
  series = {Stem Cell Research},
  volume    = {11},
  journal   = {Stem Cell Research},
  number    = {1},
  pages     = {552 -- 562},
  subject      = {Assay},
  language  = {en}
}
@article{RosnerSchipanyGundackeretal.,
  author    = {Rosner, Margit and Schipany, Katharina and Gundacker, Claudia and Shanmugasundaram, Parthasaraty and Li, Kongzhao and Fuchs, Christiane and Lubec, Gert and Hengstschl{\"a}ger, Martin},
  title     = {Renal differentiation of amniotic fluid stem cells: perspectives for clinical application and for studies on specific human genetic diseases},
  series = {Eur J Clin Invest},
  journal   = {Eur J Clin Invest},
  subject      = {Stem Cells},
  language  = {en}
}
@article{GundackerScheinastDamjanovicetal.,
  author    = {Gundacker, Claudia and Scheinast, Matthias and Damjanovic, Lukas and Fuchs, Christiane and Rosner, Margit and Hengstschl{\"a}ger, Markus},
  title     = {Proliferation potential of human amniotic fluid stem cells differently respondes to mercury and lead exposure},
  series = {Amino Acids},
  journal   = {Amino Acids},
  subject      = {Stem Cells},
  language  = {en}
}
@article{RosnerFuchsDolznigetal.,
  author    = {Rosner, Margit and Fuchs, Christiane and Dolznig, Helmut and Hengstschl{\"a}ger, Markus},
  title     = {Different cytoplasmic/nucelar distribution of S6 protein phosphorylated at S240/244 and S235/236},
  series = {Amino Acids},
  journal   = {Amino Acids},
  number    = {40},
  pages     = {595 -- 600},
  subject      = {Proteins},
  language  = {en}
}
@misc{MuehlederFuchsBassilioetal.,
  author    = {M{\"u}hleder, Severin and Fuchs, Christiane and Bassilio, Jose and Sczwarc, Dorota and Pill, Karoline and Slezak, Paul and Labuda, Krystina and Siehs, Christian and Pr{\"o}ll, Johannes and Priglinger, Eleni and Redl, Heinz and Holnthoner, Wolfgang},
  title     = {The purinergic receptor P2Y2 modulates endothelial sprouting and angiogenesis},
  subject      = {Angiogenesis},
  language  = {en}
}
@article{PriglingerSchuhSteffenhagenetal.,
  author    = {Priglinger, Eleni and Schuh, Christina and Steffenhagen, Carolin and Wurzer, Christoph and Maier, Julia and N{\"u}rnberger, Sylvia and Holnthoner, Wolfgang and Fuchs, Christiane and Suessner, Susanne and R{\"u}nzler, Dominik and Redl, Heinz and Wolbank, Susanne},
  title     = {Improvement of adipose tissue-derived cells by low-energy extracorporeal shock wave therapy.},
  series = {Cytotherapy},
  journal   = {Cytotherapy},
  pages     = {1079 -- 1095},
  abstract  = {BACKGROUND: Cell-based therapies with autologous adipose tissue-derived cells have shown great potential in several clinical studies in the last decades. The majority of these studies have been using the stromal vascular fraction (SVF), a heterogeneous mixture of fibroblasts, lymphocytes, monocytes/macrophages, endothelial cells, endothelial progenitor cells, pericytes and adipose-derived stromal/stem cells (ASC) among others. Although possible clinical applications of autologous adipose tissue-derived cells are manifold, they are limited by insufficient uniformity in cell identity and regenerative potency. METHODS: In our experimental set-up, low-energy extracorporeal shock wave therapy (ESWT) was performed on freshly obtained human adipose tissue and isolated adipose tissue SVF cells aiming to equalize and enhance stem cell properties and functionality. RESULTS: After ESWT on adipose tissue we could achieve higher cellular adenosine triphosphate (ATP) levels compared with ESWT on the isolated SVF as well as the control. ESWT on adipose tissue resulted in a significantly higher expression of single mesenchymal and vascular marker compared with untreated control. Analysis of SVF protein secretome revealed a significant enhancement in insulin-like growth factor (IGF)-1 and placental growth factor (PLGF) after ESWT on adipose tissue. DISCUSSION: Summarizing we could show that ESWT on adipose tissue enhanced the cellular ATP content and modified the expression of single mesenchymal and vascular marker, and thus potentially provides a more regenerative cell population. Because the effectiveness of autologous cell therapy is dependent on the therapeutic potency of the patient's cells, this technology might raise the number of patients eligible for autologous cell transplantation.},
  subject      = {Shockwave Therapy},
  language  = {en}
}